Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
[1] [2] Nausea was most commonly reported during the early weeks of treatment or following each dose increase, and the majority of episodes were classified as mild to moderate in severity
Yes, the FDA is phasing out compounded Semaglutide that is essentially a copy of FDA-approved products, with deadlines in April and May 2025 for pharmacies to stop dispensing these versions
PlexusDx makes semaglutide accessible at $189 per month, with no insurance requirement and HSA/FSA eligibility, so cost is not a barrier to treatment once you and your doctor decide the timing is right
Food and Drug Administration approved the use of liraglutide for obese children between ages 12 and 17, and it approved the use of semaglutide in 2022
Gallina Barbaresco
Our telehealth platform connects you with experts in as little as 24 hours
